A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Clinical trial NCT06265727 · RECRUITING

Trial details

NCT number: NCT06265727
Sponsor: Corbus Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-04-01
Primary completion: 2027-01-16
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.